Citadel Advisors
NAUT icon

Citadel Advisors’s Nautilus Biotechnolgy NAUT Stock Holding History

Citadel Advisors’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37K Buy
+19,800
New +$52.3K ﹤0.01% 13249
2025
Q2 		– Sell
-6,000
Closed -$5.17K – 14160
2025
Q1 		$5.17K Buy
+6,000
New +$8.92K ﹤0.01% 13837
2024
Q4 		– Sell
-100
Closed -$285 – 15083
2024
Q3 		$285 Sell
100
-400
-80% -$1.03K ﹤0.01% 14055
2024
Q2 		$1.17K Sell
500
-1,300
-72% -$3.39K ﹤0.01% 13852
2024
Q1 		$5.29K Buy
1,800
+200
+13% +$567 ﹤0.01% 13752
2023
Q4 		$4.78K Buy
1,600
+1,500
+1,500% +$4.29K ﹤0.01% 13483
2023
Q3 		$316 Sell
100
-7,600
-99% -$24.7K ﹤0.01% 14087
2023
Q2 		$29.8K Sell
7,700
-15,900
-67% -$45.8K ﹤0.01% 12360
2023
Q1 		$65.4K Buy
+23,600
New +$49.5K ﹤0.01% 11818
2022
Q1 		– Sell
-16,500
Closed -$85K – 14238
2021
Q4 		$85K Buy
16,500
+3,800
+30% +$20.3K ﹤0.01% 12876
2021
Q3 		$78K Buy
+12,700
New +$101K ﹤0.01% 13088
2021
Q2 		– Sell
-28,700
Closed -$395K – 14136
2021
Q1 		$395K Buy
+28,700
New +$398K ﹤0.01% 10208

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors's NAUT Position: Q2 2026 in Review

Citadel Advisors opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 1,896,192 shares worth $3.55M. The stake represents ﹤0.01% of the portfolio and ranks #5357 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in NAUT as recently as Q3 2025.

Citadel Advisors first reported a position in NAUT in Q3 2020 and has held it in 19 quarters since. The position peaked at $4.17M in Q1 2021. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Citadel Advisors held 1,896,192 shares of Nautilus Biotechnolgy worth $3.55M as of Q2 2026.
  • Nautilus Biotechnolgy was a new Citadel Advisors position in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #5357 holding.
  • Citadel Advisors first reported a position in Nautilus Biotechnolgy in Q3 2020 and has held it in 19 quarters since.
  • Citadel Advisors's Nautilus Biotechnolgy position peaked at $4.17M in Q1 2021.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.